Robert Durcan

I am a clinical research fellow in the Rowe group. I am undertaking a PhD in the role of noradrenaline in neurodegenerative disease, using novel imaging techniques with MRI and PET. I am involved in the currently enrolling randomised control trial NORAPS, using atomoxetine in Progressive Supranuclear Palsy (PSP).